TrialDiabetologia2006
The insulin sensitiser pioglitazone does not influence skin microcirculatory function in patients with type 2 diabetes treated with insulin.
J E Tooke et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it